Detailed Mechanism Funding and Narrative

Years of mechanism: 2010 2011 2012 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 9183
Country/Region: Uganda
Year: 2016
Main Partner: The AIDS Support Organization
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $8,703,140 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $1,710,303
Care: TB/HIV (HVTB) $415,487
Care: Pediatric Care and Support (PDCS) $620,400
Laboratory Infrastructure (HLAB) $0
Health Systems Strengthening (OHSS) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $1,102,675
Testing: HIV Testing and Counseling (HVCT) $649,620
Sexual Prevention: Other Sexual Prevention (HVOP) $260,808
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $171,161
Treatment: Adult Treatment (HTXS) $3,555,115
Treatment: Pediatric Treatment (PDTX) $217,570
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV Age/Sex: <10 Female 2017 94
GEND_GBV Age/Sex: <10 Female 2017 58
GEND_GBV Age/Sex: <10 Male 2017 57
GEND_GBV Age/Sex: <10 Male 2017 35
GEND_GBV Age/Sex: 10-14 Female 2017 259
GEND_GBV Age/Sex: 10-14 Female 2017 167
GEND_GBV Age/Sex: 10-14 Male 2017 57
GEND_GBV Age/Sex: 10-14 Male 2017 35
GEND_GBV Age/Sex: 15-19 Female 2017 294
GEND_GBV Age/Sex: 15-19 Female 2017 458
GEND_GBV Age/Sex: 15-19 male 2017 56
GEND_GBV Age/Sex: 15-19 Male 2017 88
GEND_GBV Age/Sex: 20-24 Female 2017 310
GEND_GBV Age/Sex: 20-24 Female 2017 456
GEND_GBV Age/Sex: 20-24 Male 2017 94
GEND_GBV Age/Sex: 20-24 Male 2017 58
GEND_GBV Age/Sex: 25-49 Female 2017 120
GEND_GBV Age/Sex: 25-49 Female 2017 185
GEND_GBV Age/Sex: 25-49 Male 2017 94
GEND_GBV Age/Sex: 25-49 Male 2017 58
GEND_GBV By PEP service provision (related to sexual violence services provided) 2017 106
GEND_GBV By PEP service provision (related to sexual violence services provided) 2017 167
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2017 259
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2017 403
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2017 932
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2017 1,439
GEND_GBV Number of people receiving post-GBV care 2017 1,842
GEND_GBV Number of people receiving post-GBV care 2017 1,191
GEND_GBV Sum of Age/Sex Disaggregates 2017 295
GEND_GBV Sum of Age/Sex Disaggregates 2017 467
HTS_TST Age/sex: <1 2017 637
HTS_TST Age/sex: <1 2017 1,947
HTS_TST Age/sex: 1-9 2017 2,081
HTS_TST Age/sex: 1-9 2017 6,420
HTS_TST Age/sex: 10-14 Female 2017 1,785
HTS_TST Age/sex: 10-14 Female 2017 5,547
HTS_TST Age/sex: 10-14 Male 2017 1,785
HTS_TST Age/sex: 10-14 Male 2017 5,539
HTS_TST Age/sex: 15-19 Female 2017 9,517
HTS_TST Age/sex: 15-19 Female 2017 13,932
HTS_TST Age/sex: 15-19 Male 2017 3,920
HTS_TST Age/sex: 15-19 Male 2017 22,779
HTS_TST Age/sex: 20-24 Female 2017 14,277
HTS_TST Age/sex: 20-24 Female 2017 20,898
HTS_TST Age/sex: 20-24 Male 2017 5,882
HTS_TST Age/sex: 20-24 Male 2017 34,173
HTS_TST Age/sex: 25-49 Female 2017 21,891
HTS_TST Age/sex: 25-49 Female 2017 32,041
HTS_TST Age/sex: 25-49 Male 2017 9,018
HTS_TST Age/sex: 25-49 Male 2017 52,398
HTS_TST Age/sex: 50+ Female 2017 1,896
HTS_TST Age/sex: 50+ Female 2017 2,781
HTS_TST Age/sex: 50+ Male 2017 783
HTS_TST Age/sex: 50+ Male 2017 4,554
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 3,145
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 9,731
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 3,143
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 9,722
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 47,581
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 69,652
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 19,603
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 113,904
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 73,472
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 203,009
HTS_TST Service Delivery Point (Facility): Index testing 2017 2,127
HTS_TST Service Delivery Point (Facility): Index testing 2017 13,883
HTS_TST Service Delivery Point (Facility): Inpatient 2017 13,133
HTS_TST Service Delivery Point (Facility): Inpatient 2017 9,114
HTS_TST Service Delivery Point (Facility): Other PITC 2017 7,493
HTS_TST Service Delivery Point (Facility): Other PITC 2017 12,218
HTS_TST Service Delivery Point (Facility): Outpatient 2017 11,419
HTS_TST Service Delivery Point (Facility): Outpatient 2017 71,553
HTS_TST Service Delivery Point (Facility): Pediatric 2017 5,445
HTS_TST Service Delivery Point (Facility): Pediatric 2017 18,853
HTS_TST Service Delivery Point (Facility): PMTCT 2017 32,260
HTS_TST Service Delivery Point (Facility): PMTCT 2017 20,970
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 1,595
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 1,828
HTS_TST Service Delivery Point (Facility): VMMC 2017 54,590
HTS_TST Sum of Age/Sex disaggregates 2017 70,754
HTS_TST Sum of Age/Sex disaggregates 2017 194,642
HTS_TST Sum of Aggregated Age/Sex <15 2017 6,288
HTS_TST Sum of Aggregated Age/Sex <15 2017 19,453
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 67,184
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 183,556
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 73,472
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 203,009
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Female 2017 54
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Female 2017 257
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Male 2017 51
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Male 2017 249
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 185
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 541
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Male 2017 63
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Male 2017 583
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 283
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 809
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Male 2017 93
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Male 2017 874
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Female 2017 427
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Female 2017 1,242
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Male 2017 145
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Male 2017 1,338
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Female 2017 38
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Female 2017 108
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Male 2017 12
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Male 2017 118
HTS_TST_POS Test Result by Age: Positive: <1 2017 7
HTS_TST_POS Test Result by Age: Positive: <1 2017 82
HTS_TST_POS Test Result by Age: Positive: 1-9 2017 51
HTS_TST_POS Test Result by Age: Positive: 1-9 2017 292
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 85
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 444
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 78
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 436
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 933
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 2,700
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 313
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 2,913
KP_PREV By key population type: Men who have sex with men who are NOT sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 110
KP_PREV By key population type: Men who have sex with men who are sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 10,618
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2017 10,728
KP_PREV Total estimated number of key population in the catchment area 2017 14,897
KP_PREV_den By key population type: Female sex workers (FSW) (Denominator: Total estimated number of key population in the catchment area) 2017 13,679
KP_PREV_den By key population type: Men who have sex with men who are NOT sex workers (Denominator: Total estimated number of key population in the catchment area) 2017 366
KP_PREV_den By key population type: Men who have sex with men who are sex workers (Denominator: Total estimated number of key population in the catchment area 2017 852
PMTCT_ART Already on ART at beginning of current pregnancy 2017 594
PMTCT_ART Already on ART at beginning of current pregnancy 2017 428
PMTCT_ART New on ART 2017 430
PMTCT_ART New on ART 2017 303
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 32,762
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 21,259
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 675
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 481
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 181
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 128
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 5
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 5
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 37
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 24
PMTCT_EID Sum of Infant Age disaggregates 2017 856
PMTCT_EID Sum of Infant Age disaggregates 2017 609
PMTCT_STAT By: Known positives at entry 2017 594
PMTCT_STAT By: Known positives at entry 2017 428
PMTCT_STAT By: Number of new positives identified 2017 473
PMTCT_STAT By: Number of new positives identified 2017 330
PMTCT_STAT Number of new ANC and L&D clients 2017 33,598
PMTCT_STAT Number of new ANC and L&D clients 2017 21,806
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 32,762
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 21,259
PMTCT_STAT Sum of Positives Status disaggregates 2017 1,067
PMTCT_STAT Sum of Positives Status disaggregates 2017 758
PP_PREV Aggregated Age/sex: <15 Female 2017 3,338
PP_PREV Aggregated Age/sex: <15 Male 2017 3,082
PP_PREV Aggregated Age/sex: 15+ Female 2017 3,918
PP_PREV Aggregated Age/sex: 15+ Male 2017 3,932
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2017 14,269
PP_PREV Total number of people in the target population 2017 80,082
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 8
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 19
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 235
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 1
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 11
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 53
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 427
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 81
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 683
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 81
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 683
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 7,196
TB_SCREENDX [Sub-Disagg of Screen Results] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 746
TB_SCREENDX [Sub-disagg of Specimen Sent] Diagnostic Test: Other (Not Xpert) 2017 75
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: other (not Xpert) 2017 719
TB_SCREENDX [Sub-disagg of Specimen Sent] Diagnostic Test: Smear Only 2017 224
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Smear only 2017 2,159
TB_SCREENDX [Sub-disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 447
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 4,318
TB_SCREENDX Screen Result: Screened Positive for TB 2017 1,802
TB_SCREENDX Screen Results: Screened Positive for TB 2017 188
TB_SCREENDX Screened for TB by Age/Sex: <15 Female 2017 348
TB_SCREENDX Screened for TB by Age/Sex: <15 Male 2017 306
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 5,717
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 54,767
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 2,946
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 28,197
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 3,715
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 3,294
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 9,317
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 89,973
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 5
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 37
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 89
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 505
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 8
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 49
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 187
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 922
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 304
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 1,516
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 304
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 1,516
TX_CURR Age/Sex: <1 2017 15
TX_CURR Age/Sex: <1 2017 276
TX_CURR Age/Sex: <1-9 2017 1,680
TX_CURR Age/Sex: 1-9 2017 172
TX_CURR Age/Sex: 10-14 Female 2017 250
TX_CURR Age/Sex: 10-14 Female 2017 2,711
TX_CURR Age/Sex: 10-14 Male 2017 217
TX_CURR Age/Sex: 10-14 Male 2017 2,342
TX_CURR Age/Sex: 15-19 Female 2017 289
TX_CURR Age/Sex: 15-19 Female 2017 2,739
TX_CURR Age/Sex: 15-19 Male 2017 88
TX_CURR Age/Sex: 15-19 Male 2017 841
TX_CURR Age/Sex: 20-24 Female 2017 1,315
TX_CURR Age/Sex: 20-24 Female 2017 12,596
TX_CURR Age/Sex: 20-24 Male 2017 591
TX_CURR Age/Sex: 20-24 Male 2017 5,640
TX_CURR Age/Sex: 25-49 Female 2017 3,824
TX_CURR Age/Sex: 25-49 Female 2017 36,693
TX_CURR Age/Sex: 25-49 Male 2017 2,119
TX_CURR Age/Sex: 25-49 Male 2017 20,306
TX_CURR Age/Sex: 50+ Female 2017 289
TX_CURR Age/Sex: 50+ Female 2017 2,739
TX_CURR Age/Sex: 50+ Male 2017 148
TX_CURR Age/Sex: 50+ Male 2017 1,410
TX_CURR Aggregated Age/Sex: <15 Female 2017 348
TX_CURR Aggregated Age/Sex: <15 Female 2017 3,715
TX_CURR Aggregated Age/Sex: <15 Male 2017 306
TX_CURR Aggregated Age/Sex: <15 Male 2017 3,294
TX_CURR Aggregated Age/Sex: 15+ Female 2017 5,717
TX_CURR Aggregated Age/Sex: 15+ Female 2017 54,767
TX_CURR Aggregated Age/Sex: 15+ Male 2017 2,946
TX_CURR Aggregated Age/Sex: 15+ Male 2017 28,197
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 9,317
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 89,973
TX_CURR Sum of age/sex disaggregates 2017 3,580
TX_CURR Sum of Age/Sex disaggregations 2017 377
TX_CURR Sum of Aggregated Age/Sex <15 2017 654
TX_CURR Sum of Aggregated Age/Sex <15 2017 7,009
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 8,663
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 82,964
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 9,317
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 89,973
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 62
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 626
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 41
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 554
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 1,354
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 6,435
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 708
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 3,313
TX_NEW By Age/Sex: <1 2017 47
TX_NEW By Age/Sex: 1-9 2017 14
TX_NEW By Age/Sex: 1-9 2017 282
TX_NEW By Age/Sex: 10-14 Female 2017 55
TX_NEW By Age/Sex: 10-14 Female 2017 459
TX_NEW By Age/Sex: 10-14 Male 2017 34
TX_NEW By Age/Sex: 10-14 Male 2017 392
TX_NEW By Age/Sex: 15-19 Female 2017 69
TX_NEW By Age/Sex: 15-19 Female 2017 323
TX_NEW By Age/Sex: 15-19 Male 2017 15
TX_NEW By Age/Sex: 15-19 Male 2017 97
TX_NEW By Age/Sex: 20-24 Female 2017 312
TX_NEW By Age/Sex: 20-24 Female 2017 1,478
TX_NEW By Age/Sex: 20-24 Male 2017 141
TX_NEW By Age/Sex: 20-24 Male 2017 663
TX_NEW By Age/Sex: 25-49 Female 2017 909
TX_NEW By Age/Sex: 25-49 Female 2017 4,311
TX_NEW By Age/Sex: 25-49 Male 2017 509
TX_NEW By Age/Sex: 25-49 Male 2017 2,385
TX_NEW By Age/Sex: 50+ Female 2017 64
TX_NEW By Age/Sex: 50+ Female 2017 323
TX_NEW By Age/Sex: 50+ Male 2017 43
TX_NEW By Age/Sex: 50+ Male 2017 168
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 2,165
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 10,928
TX_NEW Sum of Age/Sex disaggregates 2017 2,151
TX_NEW Sum of Age/Sex disaggregates 2017 10,599
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 2,165
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 10,928
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 4,738
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 56,576
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 4,264
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 50,920
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 175
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 2,182
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 153
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 1,933
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 2,592
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 30,885
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 1,344
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 15,920
TX_PVLS Numerator: Indication: Routine 2017 4,264
TX_PVLS Numerator: Indication: Routine 2017 50,920
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 195
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 2,426
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 170
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 2,148
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 2,882
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 34,322
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 1,491
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 17,680
TX_PVLS_den Denominator: Indication: Routine 2017 4,738
TX_PVLS_den Denominator: Indication: Routine 2017 56,576
TX_RET Age/Sex: <1 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 13
TX_RET Age/Sex: 1-9 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 6
TX_RET Age/Sex: 1-9 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 87
TX_RET Age/Sex: 10-14 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 19
TX_RET Age/Sex: 10-14 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 127
TX_RET Age/Sex: 10-14 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 23
TX_RET Age/Sex: 10-14 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 138
TX_RET Age/Sex: 15-19 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 16
TX_RET Age/Sex: 15-19 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 134
TX_RET Age/Sex: 15-19 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 22
TX_RET Age/Sex: 15-19 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 172
TX_RET Age/Sex: 20-24 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 80
TX_RET Age/Sex: 20-24 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 625
TX_RET Age/Sex: 20-24 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 2
TX_RET Age/Sex: 20-24 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 35
TX_RET Age/Sex: 25-49 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 222
TX_RET Age/Sex: 25-49 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,825
TX_RET Age/Sex: 25-49 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 516
TX_RET Age/Sex: 25-49 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 4,128
TX_RET Age/Sex: 50+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 18
TX_RET Age/Sex: 50+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 139
TX_RET Age/Sex: 50+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 178
TX_RET Age/Sex: 50+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,398
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 21
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 170
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 27
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 195
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 336
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 2,723
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 718
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 5,733
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 1,102
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 8,821
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 1,239
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 9,911
TX_RET_den Age/Sex: >1 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 17
TX_RET_den Age/Sex: 1-9 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 6
TX_RET_den Age/Sex: 1-9 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 97
TX_RET_den Age/Sex: 10-14 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 19
TX_RET_den Age/Sex: 10-14 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 143
TX_RET_den Age/Sex: 10-14 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 24
TX_RET_den Age/Sex: 10-14 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 156
TX_RET_den Age/Sex: 15-19 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 18
TX_RET_den Age/Sex: 15-19 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 152
TX_RET_den Age/Sex: 15-19 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 24
TX_RET_den Age/Sex: 15-19 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 192
TX_RET_den Age/Sex: 20-24 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 88
TX_RET_den Age/Sex: 20-24 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 704
TX_RET_den Age/Sex: 20-24 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 161
TX_RET_den Age/Sex: 20-24 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,287
TX_RET_den Age/Sex: 25-49 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 256
TX_RET_den Age/Sex: 25-49 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 2,050
TX_RET_den Age/Sex: 25-49 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 584
TX_RET_den Age/Sex: 25-49 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 4,634
TX_RET_den Age/Sex: 50+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 20
TX_RET_den Age/Sex: 50+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 153
TX_RET_den Age/Sex: 50+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 39
TX_RET_den Age/Sex: 50+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 326
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 21
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 192
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 28
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 221
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 382
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 3,059
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 808
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 6,439
VMMC_CIRC By Age: 10-14 2017 21,289
VMMC_CIRC By Age: 15-19 2017 15,832
VMMC_CIRC By Age: 20-24 2017 7,644
VMMC_CIRC By Age: 25-29 2017 4,370
VMMC_CIRC By Age: 30-49 2017 4,370
VMMC_CIRC By Age: 50+ 2017 1,085
VMMC_CIRC By circumcision technique: Surgical VMMC 2017 54,590
VMMC_CIRC Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2017 54,590
VMMC_CIRC Sum of age disaggregates (FY15-Current) 2017 54,590
VMMC_CIRC Sum of age disaggregates (Prior to FY15) 2017 45,850